Finnrick - Ensuring a Safer and More Transparent Supply Chain
Peptide Partners

Peptide Partners

Finnrick has tested 61 samples from Peptide Partners across 7 products.

Finnrick Vendor Profile
to
A
C
Peptide Partners
Tracking 7 products
61 total samples tested
Last test 2 Mar 2026

Take Action

Test My Sample
Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Products

Tests
Product
Rating
CountAvgMinMaxOldestMost Recent
BPC-157
A
Great
68.16.910.023 Oct 20256 Nov 2025
Ipamorelin
A
Great
79.99.410.023 Oct 202515 Feb 2026
Retatrutide
A
Great
158.97.010.017 Jul 20252 Mar 2026
TB-500
A
Great
68.46.510.030 Jan 202618 Feb 2026
Tesamorelin
B
Good
117.85.310.030 Jan 202620 Feb 2026
Tirzepatide
C
Okay
68.24.29.811 Jun 20253 Oct 2025
CJC-1295
C
Okay
96.74.39.44 Nov 202515 Feb 2026

Most recent Peptide Partners tests

Samples are tested in commercial labs

61

tests

7

products

Scores

AVG8.3MIN4.2MAX10.0

First

11 Jun 2025

Last

2 Mar 2026
Quantity
Test DateProductCertificateVariant
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
2 Mar 2026RetatrutideView9.324mg22.3mg-7.1%99.90%RT202602White Label / Silver Crimp / Violet CapLab EPublic
22 Feb 2026RetatrutideView9.424mg23.3mg-2.9%99.65%RT202602White Label / Silver Crimp / Violet CapLab EPublic
20 Feb 2026TesamorelinView6.710mg12.8mg+28.0%99.80%TES202601(no data)Lab GPublic
18 Feb 2026TesamorelinView5.310mg12mg+20.0%99.14%TES202601White Label / Silver Crimp / Blue CapLab EPublic
18 Feb 2026TB-500ViewThymosin Beta-46.610mg10.9mg+9.0%98.80%TB202601White Label / Silver Crimp / Blue CapLab EPublic
18 Feb 2026TB-500ViewThymosin Beta-410.010mg9.54mg-4.6%99.90%TB202601White Label / Silver Crimp / Blue CapLab EPublic
18 Feb 2026TesamorelinView6.210mg11mg+10.0%98.71%TES202601White Label / Silver Crimp / Blue CapLab EPublic

Corrections

10 Oct 2025:
Peptide Partners have elected to have all their samples tested against the label claim. The "batch claim" from COAs is not taken into account. Some test scores have been updated accordingly.